Mentions
Extended reach
Total likes
Video views
AI synopsis
Many posts highlight specific advancements, like the targeting of lysosomal damage and new experimental drugs improving gut-muscle communication, with users expressing hope for families affected by Duchenne muscular dystrophy. Phrases like "exciting news for the DMD community" and "offers hope for improving muscle health" reflect an optimistic tone, reinforcing a collective enthusiasm for forthcoming therapies.
The majority of discussions reflect strong support for the research findings, particularly regarding therapeutic targets and new drug developments.
Posts indicate a high level of curiosity and relevance around new therapeutic approaches for Duchenne muscular dystrophy.
While many posts mention important findings and news, the depth of engagement varies, with some focusing purely on sharing articles rather than in-depth discussions.
Overall, there’s a widespread belief that the new research and drug developments could significantly affect the future of treatment and management for Duchenne muscular dystrophy.
Histología de músculo sano comparado con distrofia muscular de Duchenne: Nat Rev Dis Primers 2021; DOI: https://t.co/eC6cEnO3Un https://t.co/bcA6Uc6VLk
Algoritmo sobre la decisión diagnóstica para confirmar el diagnóstico genético de distrofinopatías: Nat Rev Dis Primers 2021; DOI: https://t.co/eC6cEnO3Un https://t.co/p2FiGISuWD
Chad Williams is an exceptional man with exceptional courage. The most inspirational, strong-minded person you can meet. He is an #AVFC podcaster, fan, fundraiser, a Duchenne muscular dystrophy (DMD) campaigner and legend. This is his story @theathleticfc.bsky.social www.nytimes.com/athletic/668...
Lysosomal damage is a therapeutic target in Duchenne muscular dystrophy | Science Advances https://t.co/P8MYPBpwHY
#Duchenne News: Today, Satellos announced that the first patient has been dosed in LT-001, an open-label, long-term follow-up study of SAT-3247 in adult males with Duchenne muscular dystrophy. Full details here: https://t.co/QziVxknqqV #MuscleRegeneration $MSCL $MSCLF https://t.co/gJETURS7na
This video examines Duchenne muscular dystrophy (DMD), a severe, progressive muscle-wasting disease caused by mutations in the DMD gene. We discuss its pathogenesis, current therapies, diagnostic approaches, and the…
RT @ShorterLab: Lysosomal damage is a therapeutic target in Duchenne muscular dystrophy | Science Advances https://t.co/P8MYPBpwHY
RT @performance3pp:
RT @GGouspillou: Lysosomal damage is a therapeutic target in Duchenne muscular dystrophy | Science Advances https://t.co/NEwDYB86kW
@Pablithopinto2 As parents of children with DMD, we know that emergencies can be overwhelming. Our latest article discusses essential tips for navigating the ER with a child who has Duchenne Muscular Dystrophy. Be prepared and informed! Read more here: https://t.co/yddvKNqJLP
RT @GGouspillou: Lysosomal damage is a therapeutic target in Duchenne muscular dystrophy | Science Advances https://t.co/NEwDYB86kW
Lysosomal damage is a therapeutic target in Duchenne muscular dystrophy | Science Advances https://t.co/NEwDYB86kW
RT @Matt_Muscle_Guy: Interesting new @ScienceAdvances paper: Lysosomal damage is a therapeutic target in Duchenne muscular dystrophy. https…
RT @Matt_Muscle_Guy: Interesting new @ScienceAdvances paper: Lysosomal damage is a therapeutic target in Duchenne muscular dystrophy. https…
RT @Weggster: This is Alex Johnson OBE. She’s a force of nature. I’m privileged to call her my friend. We met as our boys have Duchenne Mu…
RT @cell_club: Lysosomal damage is a therapeutic target in Duchenne muscular dystrophy | Science Advances https://t.co/nUqGPG7UGs
RT @ShorterLab: Lysosomal damage is a therapeutic target in Duchenne muscular dystrophy | Science Advances https://t.co/P8MYPBpwHY
Lysosomal damage is a therapeutic target in Duchenne muscular dystrophy www.science.org/doi/10.1126/...
Lysosomal damage is a therapeutic target in Duchenne muscular dystrophy https://t.co/WjvJ5tIX1C
✅The correct answer is B. Dystrophin.
RT @ShorterLab: Lysosomal damage is a therapeutic target in Duchenne muscular dystrophy | Science Advances https://t.co/P8MYPBpwHY
@inoa_ole @ethan_peppers @AbortionChat @Cabecki68 Duchenne muscular dystrophy. It was absolutely heartbreaking.
RT @cell_club: Lysosomal damage is a therapeutic target in Duchenne muscular dystrophy | Science Advances https://t.co/nUqGPG7UGs
@LightningFan083 Exciting news for families affected by DMD! A new experimental drug shows promise in enhancing gut-muscle communication in mice with Duchenne Muscular Dystrophy. This could pave the way for future treatments! Read more about this breakthrough here:
Lysosomal damage is a therapeutic target in Duchenne muscular dystrophy | Science Advances https://t.co/nUqGPG7UGs
Lysosomal damage is a therapeutic target in Duchenne muscular dystrophy | Science Advances www.science.org/doi/10.1126/...
University of Minnesota research team discovers new therapy potential for Duchenne Muscular Dystrophy https://t.co/bp1OattNzS https://t.co/IrtoVnmkrN
@MDAorg Exciting news for the DMD community! A new experimental drug has shown promise in improving gut-muscle crosstalk in DMD mice, paving the way for potential therapies. This could be a significant step forward for families affected by Duchenne Muscular Dystrophy. Read more
RT @Weggster: This is Alex Johnson OBE. She’s a force of nature. I’m privileged to call her my friend. We met as our boys have Duchenne Mu…
The stairs were only six steps—but to four-year-old Marko, they might as well have been Everest. Years later, #Duchenne muscular dystrophy is still trying to slow him down… but thanks to donors like you, it never will. chivecharities.org/story/marko-...
RT @MedLearnHub:
Interesting new #ScienceAdvances paper: Lysosomal damage is a therapeutic target in Duchenne muscular dystrophy. #Myoblue tinyurl.com/mu2dvhc5
Interesting new @ScienceAdvances paper: Lysosomal damage is a therapeutic target in Duchenne muscular dystrophy. https://t.co/nBXPAg0KiS
RT @ShorterLab: Lysosomal damage is a therapeutic target in Duchenne muscular dystrophy | Science Advances https://t.co/P8MYPBpwHY
RT @LabWaggoner: Lysosomal damage is a therapeutic target in Duchenne muscular dystrophy @ScienceAdvances
Newly discovered
RT @ShorterLab: Lysosomal damage is a therapeutic target in Duchenne muscular dystrophy | Science Advances https://t.co/P8MYPBpwHY
RT @ShorterLab: Lysosomal damage is a therapeutic target in Duchenne muscular dystrophy | Science Advances https://t.co/P8MYPBpwHY
RT @ShorterLab: Lysosomal damage is a therapeutic target in Duchenne muscular dystrophy | Science Advances https://t.co/P8MYPBpwHY
RT @ShorterLab: Lysosomal damage is a therapeutic target in Duchenne muscular dystrophy | Science Advances https://t.co/P8MYPBpwHY
Lysosomal damage is a therapeutic target in Duchenne muscular dystrophy @ScienceAdvances
Lysosomal damage is a therapeutic target in Duchenne muscular dystrophy www.science.org/doi/10.1126/...
@lithiuminperu Exciting breakthrough! An experimental drug is showing promise in improving gut-muscle crosstalk in DMD mice. This could lead to new hope for families affected by Duchenne Muscular Dystrophy. Learn more about this innovative research and its potential impact:
RT @ShorterLab: Lysosomal damage is a therapeutic target in Duchenne muscular dystrophy | Science Advances https://t.co/P8MYPBpwHY
@AkdenizEfeberk Exciting breakthrough! An experimental drug shows promise in enhancing gut-muscle communication in DMD mice, potentially paving the way for new treatments. This research brings hope for families facing the challenges of Duchenne Muscular Dystrophy. Read more here:
@eMPR Exciting news! A new experimental drug shows promise in enhancing gut-muscle crosstalk in DMD mice, potentially paving the way for innovative therapies. This breakthrough offers hope for improving muscle health in children with Duchenne Muscular Dystrophy. Read more:
RT @Manithan_20: @drabdulhameed07 @IhabFathiSulima @modernHealthMe Gower's sign, Dx: Duchenne muscular dystrophy
RT @FantaCat24: @drabdulhameed07 @IhabFathiSulima @modernHealthMe Duchenne muscular dystrophy, X linked Recessive. Gower sign.
RT @Twinkle_IMR: Vectorcardiogram (VCG) may help predict reduced LVEF in #children with Duchenne Muscular Dystrophy (DMD) as early as <5 ye…
"We are aware of reports from outside the UK of deaths of people living with Duchenne muscular dystrophy (DMD) who were receiving givinostat (Duvyzat). Our thoughts are with the families affected and the wider Duchenne community." www.musculardystrophyuk.org/news/a-state...
Lysosomal damage is a therapeutic target in Duchenne muscular dystrophy | Science Advances https://t.co/P8MYPBpwHY
RT @MDUK_News: Statement from NorthStar Network UK about givinostat: We're aware of reports from outside the UK of deaths of people living…
@SUOXIHospital We're excited to share groundbreaking research! An experimental drug shows promise in improving gut-muscle crosstalk in DMD mice, paving the way for potential therapies. This could be a significant step forward for families affected by Duchenne Muscular Dystrophy.
We are proud to support @defeatduchenne’s 2025 Family Forum on October 25-26. Patrick Gonzalez, Ph.D., our Head of Clinical Science, will speak about our investigational gene therapy for #Duchenne muscular dystrophy, SGT-003, on Sunday, October 26, at 2:50 PM ET. Stop by our https://t.co/FPqxAiHxNO
RT @CheckOrphan: Satellos Announces First Adult Patient Dosed in LT-001, an Open-Label, Long-Term Follow-Up Study of SAT-3247 in Duchenne M…
Statement from NorthStar Network UK about givinostat: We're aware of reports from outside the UK of deaths of people living with Duchenne muscular dystrophy (DMD) who were receiving givinostat (Duvyzat). Our thoughts are with the families affected and wider Duchenne community.
@FFD_USA Exciting news for the DMD community! A new experimental drug has shown promise in improving gut-muscle crosstalk in DMD mice, potentially paving the way for innovative therapies. This could be a significant step forward in the fight against Duchenne Muscular Dystrophy.
If you are at American Academy of Physical Medicine & Rehabilitation (@AAPMR) #AAPMR25, visit Team Catalyst at booth #1509 to learn more about rare diseases like Lambert-Eaton myasthenic syndrome (LEMS) and Duchenne muscular dystrophy (DMD), and how we're bringing more awareness https://t.co/TBsghbr1ga
@umnmedschool Exciting news for families affected by Duchenne Muscular Dystrophy (DMD)! A groundbreaking experimental drug has shown promise in enhancing gut-muscle communication in DMD mice. This could pave the way for new therapies in the future. Learn more about this hopeful
10) Nuance: Screening out catastrophic monogenic disorders like Sanfilippo Syndrome, Huntington’s, Cystic Fibrosis, Tay–Sachs, Duchenne Muscular Dystrophy, etc — this is based on legitimate science / clinical practice — and is a choice I personally would never dare to judge but,
Satellos Announces First Adult Patient Dosed in LT-001, an Open-Label, Long-Term Follow-Up Study of SAT-3247 in Duchenne Muscular Dystrophy - For More Information Visit https://t.co/Uik2z4dZoJ @SatellosBio #Duchenne #DMD #Muscular_Dystrophy #OrphanDrugs #Drug_research https://t.co/mvw9kK8LO8
Light of life, lighting the way ahead! On October 20, A Flame in the Rain, an autobiographical essay collection by Wu Chengyu — a young man living with the rare disease Duchenne Muscular Dystrophy (DMD) — was warmly launched in Fuzhou. “I wish to be the torch at the feet of one https://t.co/YIF64dTX1I
RT @MilaBonu: @Cr7Fran4ever @Cristiano @AlNassrFC Dear Cristiano Ronaldo, please help my son. My son's name is Ravshanbekov Emir Davronbeko…
@Cr7Fran4ever @Cristiano @AlNassrFC Dear Cristiano Ronaldo, please help my son. My son's name is Ravshanbekov Emir Davronbekovich. He was born on 04/20/2020. Today, he has been diagnosed with a rare genetic disease - Duchenne muscular dystrophy. The drug Elevidys infusion costs $ 3 000 000. Please help us
RT @TheLeapKandula: #MustRead and #MustShare
RT @SteveMaclin: .@DeonnaPurrazzo & I, alongside @MrsAIPAlisha, are joining JAR of Hope @runDisney 5k this April to make an IMPACT to end D…
RT @MrsAIPAlisha: SPECIAL ANNOUNCEMENT I’ll be participating in the Disney 5K race on April 14 representing @IMPACTWRESTLING and @jarofho…
RT @SatellosBio: #Duchenne News: Today, Satellos announced that the first patient has been dosed in LT-001, an open-label, long-term follow…
RT @SatellosBio: #Duchenne News: Today, Satellos announced that the first patient has been dosed in LT-001, an open-label, long-term follow…
RT @SatellosBio: #Duchenne News: Today, Satellos announced that the first patient has been dosed in LT-001, an open-label, long-term follow…
@DDWJournal Understanding how genetic variants influence DMD treatment and prognosis is crucial for families navigating this journey. Discover insights that can empower you and your loved ones in managing Duchenne Muscular Dystrophy. Read more here: https://t.co/8kdzLY23aK
Annual Cali RAD Fest 11/9 at Weir Beer in Vista. Mark your calendars & come out to support a good cause. Cali-RAD = California Reggae Against Duchenne. This charity event directly supports the mission of CureDuchenne, dedicated to finding a cure for Duchenne muscular dystrophy. https://t.co/J8oLJTe3eX
@rsamaan Discover how genetic variants can influence treatment and prognosis for DMD. This article sheds light on the complexities of Duchenne Muscular Dystrophy and offers insights that may help families navigate their journey. Read more here: https://t.co/8kdzLY23aK
RT @SatellosBio: #Duchenne News: Today, Satellos announced that the first patient has been dosed in LT-001, an open-label, long-term follow…
@LWang_UIowa Dive into our latest article exploring how genetic variants influence DMD treatment and prognosis. Understanding these factors can empower families facing Duchenne Muscular Dystrophy. Together, we can make informed decisions for better outcomes. Read more:
@ISSCR Discover how genetic variants can influence DMD treatment and prognosis in this insightful article. Understanding these factors is crucial for parents navigating their child's journey with Duchenne Muscular Dystrophy. Read more here: https://t.co/8kdzLY23aK
@Biotechnerd1 Understanding how genetic variants affect DMD treatment and prognosis can empower families facing this challenge. Our latest article dives deep into the science behind Duchenne Muscular Dystrophy. Knowledge is a crucial step in the journey. Read more here:
RT @SatellosBio: #Duchenne News: Today, Satellos announced that the first patient has been dosed in LT-001, an open-label, long-term follow…
RT @thinksabio: #Trendingsector #ThinkSabio #Trendingstock $SPX $SPY $XBI $QQQ $IWM #Markets #StockMarket #Stocks #Trending #mag7 BIO CATA…
RT @SatellosBio: #Duchenne News: Today, Satellos announced that the first patient has been dosed in LT-001, an open-label, long-term follow…
$MSCL as Satellos Announces First Adult Patient Dosed in LT-001, an Open-Label, Long-Term Follow-Up Study of SAT-3247 in Duchenne Muscular Dystrophy More Info: https://t.co/ejgNL7aZ2k https://t.co/3dENPeXQNl
A breakthrough for Duchenne Muscular Dystrophy: an interdisciplinary UMN research team, including Chemistry Regents Prof. Timothy Lodge, has developed a therapeutic approach that is about 150,000 times more effective than similar existing treatments. Published in PNAS!
@ian_gravelle Discover how genetic variants can influence treatment and prognosis for children with DMD. This article offers valuable insights for families navigating the complexities of Duchenne Muscular Dystrophy. Read more here: https://t.co/8kdzLY23aK
RT @TheLeapKandula: #MustRead and #MustShare
RT @SatellosBio: #Duchenne News: Today, Satellos announced that the first patient has been dosed in LT-001, an open-label, long-term follow…
Satellos Announces First Adult Patient Dosed in LT-001, an Open-Label, Long-Term Follow-Up Study of SAT-3247 in Duchenne Muscular Dystrophy https://t.co/c3gefus4Bq https://t.co/HMUi2AvOPE
RT @SatellosBio: #Duchenne News: Today, Satellos announced that the first patient has been dosed in LT-001, an open-label, long-term follow…
#Duchenne News: Today, Satellos announced that the first patient has been dosed in LT-001, an open-label, long-term follow-up study of SAT-3247 in adult males with Duchenne muscular dystrophy. Full details here: https://t.co/QziVxknqqV #MuscleRegeneration $MSCL $MSCLF https://t.co/gJETURS7na
#Duchenne News: Today, Satellos announced that the first patient has been dosed in LT-001, an open-label, long-term follow-up study of SAT-3247 in adult males with Duchenne muscular dystrophy. Full details here: https://t.co/QziVxknqqV #MuscleRegeneration https://t.co/IuSAtLFpAA
Satellos Announces First Adult Patient Dosed in LT-001, an Open-Label, Long-Term Follow-Up Study of SAT-3247 in Duchenne Muscular Dystrophy $MSCL.TO https://t.co/v1qRdWufJb
@drabdulhameed07 @IhabFathiSulima @modernHealthMe Gower's sign, Dx: Duchenne muscular dystrophy
@drabdulhameed07 @IhabFathiSulima @modernHealthMe Duchenne muscular dystrophy, X linked Recessive. Gower sign.
RT @TheLeapKandula: #MustRead and #MustShare
RT @TheLeapKandula: #MustRead and #MustShare
@DYue005 Discover how genetic variants can influence treatment options and prognosis for DMD. This insightful article sheds light on the complexities of Duchenne Muscular Dystrophy and offers hope for families navigating this journey. Read more here: https://t.co/8kdzLY23aK
@EvanBolton Discover how genetic variants play a crucial role in the treatment and prognosis of DMD. This insightful article sheds light on the complexities of Duchenne Muscular Dystrophy and offers hope for tailored approaches. Read more here: https://t.co/8kdzLY23aK
Excited to attend the Oligonucleotide Therapeutics Society (OTS) Annual Meeting in Budapest!
Evaluating exon-skipping therapies targeting the central nervous system in Duchenne muscular dystrophy using high-resolution spatial transcriptomics https://www.biorxiv.org/content/10.1101/2025.10.20.683239v1
Evaluating exon-skipping therapies targeting the central nervous system in Duchenne muscular dystrophy using high-resolution spatial transcriptomics https://www.biorxiv.org/content/10.1101/2025.10.20.683239v1
@Lycanbull Discover how genetic variants can shape treatment options and prognosis for DMD. This insightful article provides hope and guidance for families navigating Duchenne Muscular Dystrophy. Learn more here: https://t.co/8kdzLY23aK
@biTuna178423 Discover how genetic variants can influence treatment options and prognosis for DMD. This insightful article sheds light on the importance of personalized approaches in managing Duchenne Muscular Dystrophy. Empower yourself with knowledge! Read more here:
@NIH_CSR Hello, everyone! Could you please tell me if there are any current clinical trials or programs for Duchenne muscular dystrophy? My name is Natalia, my son Roman is 7.5 years old, and he has Duchenne muscular dystrophy (DMD) with a deletion of 50-52. He's walking and not taking
@radio_festival Understanding how genetic variants affect DMD treatment and prognosis is crucial for families navigating this journey. Our latest article sheds light on the complexities of Duchenne Muscular Dystrophy and offers insight into personalized care. Read more here:
@MHExecutive Discover how genetic variants can influence treatment options and prognosis for children with DMD. This essential read can help parents understand the complexities of Duchenne Muscular Dystrophy and empower their journey. Learn more here: https://t.co/8kdzLY23aK
@kalipolis Explore how genetic variants influence DMD treatment and prognosis in our latest article. Understanding these factors can empower families facing Duchenne Muscular Dystrophy. Dive into the details and discover new insights that could make a difference for your child:
A timely and significant publication on gene therapy considerations for Duchenne muscular dystrophy. @worldduchenne.bsky.social @duchennenl.bsky.social #Duchennemusculardystrophy #DMDhttps://www.sciencedirect.com/science/article/pii/S0960896625009356?via%3Dihub
"Jesse did not live to see today. But I think that he'd be very proud of what's happened, and I know I'm very excited about what the future can bring for boys with #Duchenne because we're on the right track." - John Davidson The journey continues: https://t.co/RbDr83l3mk https://t.co/NZ1G2eVdbx
@MinervaCap Understanding how genetic variants affect Duchenne Muscular Dystrophy (DMD) treatment and prognosis is crucial for families navigating this journey. Our latest article sheds light on these impacts and offers insights for better decision-making. Read more here:
@Cr7Fran4ever @Cristiano @AlNassrFC Dear Elon Mask, please help my son. My son's name is Ravshanbekov Emir Davronbekovich. He was born on 04/20/2020. Today, he has been diagnosed with a rare genetic disease - Duchenne muscular dystrophy. The drug Elevidys infusion costs $ 3 000 000. Please help us
@Cr7Fran4ever @Cristiano @AlNassrFC Dear Cristiano Ronaldo , please help my son. My son's name is Ravshanbekov Emir Davronbekovich. He was born on 04/20/2020. Today, he has been diagnosed with a rare genetic disease - Duchenne muscular dystrophy. The drug Elevidys infusion costs $ 3 000 000. Please help us
@ErlingHaaland Dear @ErlingHaaland, please help my son. My son's name is Ravshanbekov Emir Davronbekovich. He was born on 04/20/2020. Today, he has been diagnosed with a rare genetic disease - Duchenne muscular dystrophy. The drug Elevidys infusion costs $ 3 000 000. Please help us
The Duchenne muscular dystrophy landscape is changing fast. New therapies. New molecular insights. New expectations for patient outcomes. Join us for a case-based, interactive session on advancing Duchenne muscular dystrophy care.
The Duchenne muscular dystrophy landscape is changing fast. New therapies. New molecular insights. New expectations for patient outcomes. Join us for a case-based, interactive session on advancing Duchenne muscular dystrophy care.
The Duchenne muscular dystrophy landscape is changing fast. New therapies. New molecular insights. New expectations for patient outcomes. Join us for a case-based, interactive session on advancing Duchenne muscular dystrophy care.
@siemionowkris Discover how genetic variants influence treatment and prognosis for DMD. This insightful article offers hope and clarity for families navigating Duchenne Muscular Dystrophy. Together, we can better understand the path ahead. Read more here: https://t.co/8kdzLY23aK
A Potential Beta-hydroxybutyrate Therapy for Duchenne Muscular Dystrophy in Disease Models https://www.biorxiv.org/content/10.1101/2025.10.18.683257v1
A Potential Beta-hydroxybutyrate Therapy for Duchenne Muscular Dystrophy in Disease Models https://www.biorxiv.org/content/10.1101/2025.10.18.683257v1
2015: Happy 10 years, C-Path! New consortia launched for neonatal drug development, Duchenne muscular dystrophy, and Parkinson’s disease. WHO selects C-Path to host TB clinical trials data. Learn more about #CPath20Years here: https://f.mtr.cool/wtducgftkk
Join experts Emma Ciafaloni, MD, FAAN and Aravindhan Veerapandiyan, MD for a case-based, interactive session on advancing Duchenne muscular dystrophy care.
Join experts Emma Ciafaloni, MD, FAAN and Aravindhan Veerapandiyan, MD for a case-based, interactive session on advancing Duchenne muscular dystrophy care.
TXBN Trending: Duchenne Muscular Dystrophy Therapeutics Market Surges Toward $6.6B by 2033 as Gene and RNA Therapies Redefine Treatment Paradigm | by DataM Intelligence https://zpr.io/XiaA246nLuSS
New #DMM_Journal paper: Characterization of a humanized mouse model of Duchenne muscular dystrophy to support the development of genetic medicines. #Myoblue tinyurl.com/42m653r2
Signal or noise? > Duchenne Muscular Dystrophy Therapeutics Market Surges Toward $6.6B by 2033 as Gene and RNA Therapies Redefine Treatment Paradigm | by DataM Intelligence >> Comment below! #mhealth #industry40 #IoT #healthtech #AI
Signal or noise? > Duchenne Muscular Dystrophy Therapeutics Market Surges Toward $6.6B by 2033 as Gene and RNA Therapies Redefine Treatment Paradigm | by DataM… >> Comment below! #strategy #competitiveintelligence #marketing #biotech #pharmaceutical #healthcare #competitivemarketing #pharma
Duchenne Muscular Dystrophy Therapeutics Market Projected to Reach $6.6 Billion by 2033 Amidst Revolutionary Therapies #None #gene_therapy #RNA_Therapies #Duchenne_Muscular_Dystrophy
We are proud to announce that BioSymetrics (a @lunaibioworks.bsky.social company), Leiden University Medical Center, and @ufresearch.bsky.social have co-authored a new Nature Communications study identifying serum proteins that predict disease progression in Duchenne muscular dystrophy (DMD).
#LNAI Landmark Study Identifies Prognostic Biomarkers in Duchenne Muscular Dystrophy Using Large-Scale Serum Proteomics https://www.stocktitan.net/news/LNAI/landmark-study-identifies-prognostic-biomarkers-in-duchenne-muscular-i2v8du7jgvf4.html
Read more about Capricor’s drug for Duchenne muscular dystrophy, rejected earlier this year amid tensions within the FDA: www.statnews.com/2025/07/11/f... #STATSummit
Duchenne muscular dystrophy is characterized by progressive muscle function loss. Patients usually lose ambulation between the ages of 10 and 16, but there is heterogeneity between patients, so it is better to characterize by disease stage than age.
Teenager who received Elevidys, Sarepta's Duchenne gene therapy, dies - STAT Sarepta Therapeutics said that a young man died after receiving Elevidys, its gene therapy for Duchenne muscular dystrophy
The novel approach developed here uses a combination oligonucleotide therapy to treat musculoskeletal diseases involving elevated TGF-β activity, with a particular focus on Duchenne muscular dystrophy.
Synthetic bottlebrush block copolymer prevents disease onset in Duchenne muscular dystrophy www.pnas.org/doi/10.1073/...
EMILIN1 emerges as a TGFbeta/SETDB1-regulated secreted biomarker in Duchenne Muscular Dystrophy https://www.biorxiv.org/content/10.1101/2025.10.11.681604v1
EMILIN1 emerges as a TGFbeta/SETDB1-regulated secreted biomarker in Duchenne Muscular Dystrophy https://www.biorxiv.org/content/10.1101/2025.10.11.681604v1
New @NatureComms paper: Large-scale serum protein biomarkers discovery associated with function and clinical milestones in Duchenne muscular dystrophy. #DMD #Myoblue tinyurl.com/34nufjed
Discovering Key Serum Biomarkers in Duchenne Muscular Dystrophy In a groundbreaking advance for neuromuscular medicine, a team of researchers has unveiled an extensive catalog of serum protein biomarkers intricately linked with functional status and clinical progression in Duchenne muscular…
Does Pulsed Electromagnetic Field (PEMF) Therapy Treat Duchenne Muscular Dystrophy and Initiate Dystrophin Production? #pemf #dmd #duchenne
Serum biomarkers in Duchenne muscular dystrophy: a leap toward precision diagnostics #EurJTranslMyol #MassSpec www.pagepressjournals.org/bam/article/...
#DMCNPlainLanguageSummary Height, weight, and body mass index trajectories and their correlation with functional outcome assessments in young males with Duchenne muscular dystrophy onlinelibrary.wiley.com/doi/10.1111/...
「医療 サイト ツール」に関する記事です: https://www.qlifepro.com/news/20251010/duchenne-muscular-dystrophy-2.html
Duchenne muscular dystrophy (DMD) is caused by lack of dystrophin. This leads to chronic muscle damage, inflammation, and replacement of muscle by fat and adipose tissues. Later patients also develop cardiomyopathy and a subset of patients also has cognitive and/or behavior comorbidities.
#apaperaday the last #WMS2025 @worldmusclesociety.org themed paper, a review by Relaix et al on rat models for Duchenne muscular dystrophy, published in Skeletal Muscle and specifically flagged by the journal for #WDAD2025 @worldduchenne.bsky.social. DOI: 10.1186/s13395-025-00395-1
Congratulations to the CMR's @kristyswid.bsky.social and Prof Gordon Lynch for their new review paper on "Translational progress in the development of pharmacotherapies for Duchenne muscular dystrophy" www.tandfonline.com/doi/full/10.... @mda.org
@genethonfr.bsky.social confirms long-term efficacy of its GNT0004 gene therapy for Duchenne muscular dystrophy at @ESGCT & @WorldMuscleSoc - Improved motor function - Slowed disease progression - Sustained reduction in CPK levels - No serious side effects urlr.me/kmfg9M
Translational progress in the development of pharmacotherapies for Duchenne muscular dystrophy www.tandfonline.com/doi/full/10....
Translational progress in the development of pharmacotherapies for Duchenne muscular dystrophy www.tandfonline.com/doi/full/10....
Open Access UCL Research: Incorporating data insights and clinical knowledge in statistical methodologies: Modelling disease trajectories in children with Duchenne Muscular Dystrophy and Spinal Muscular Atrophy discovery.ucl.ac.uk/id/eprint/10...
Question: What’s the future of Duchenne Muscular Dystrophy (DMD) treatment?
Signal or noise? > Duchenne Muscular Dystrophy Drugs Market Global Forecast - GlobeNewswire >> Comment below! #strategy #competitiveintelligence #marketing #biotech #pharmaceutical #competitivemarketing #healthcare #pharma
i think these people do this shit on purpose because they enjoy making me feel like i'm trapped in the hypercube between and around all space and time
Poster at ESGCT:
England
Prof. Dr. B. S. Rajput, Consultant Orthopaedic & Cellular Transplant Surgeon at ACI Cumballa Hill Hospital, Mumbai.
Chad Williams is an exceptional man with exceptional courage. The most inspirational, strong-minded person you can meet. He is an #AVFC podcaster, fan, fundraiser, a Duchenne muscular dystrophy (DMD) campaigner and legend. This is his story @theathleticfc.bsky.social www.nytimes.com/athletic/668...
Signal or noise? > Duchenne Muscular Dystrophy Market Report 2034: Epidemiology, Pipeline Therapies, and Recent Regulatory Approvals by DelveInsight | Featuring Sarepta… >> Comment below! #strategy #competitiveintelligence #marketing #biotech #pharmaceutical #competitivemarketing #healthcare #pharma
It’s Becker Muscular Dystrophy Awareness Week. #BMD #BeckerMD #MuscularDystrophy #BeckerMuscularDystrophy
SonoThera™ Presents New Data at ESGCT 2025 Demonstrating Expression of Full-Length Human Dystrophin Using Targeted, Ultrasound-Mediated Delivery to Treat Duchenne Muscular Dystrophy - www.businesswire.com/news/home/20...
Included in the collection: Tom Roberts and his group contributed a review on the progress and prospects in antisense oligonucleotide-mediated exon skipping therapies for Duchenne muscular dystrophy doi.org/10.1007/s109... 4/8
A team of researchers from the US and Korea developed a TGF-β-#TPMO that could be beneficial in Duchenne muscular dystrophy (#DMD) when used in combination with #DPMO. @moltherapy.bsky.social Read more: https://bit.ly/4gV0LX8 #RareDisease #DuchenneMuscularDystrophy #MedSky
Duchenne muscular dystrophy (DMD) is caused by lack of dystrophin. In 10-15% this is due to a nonsense mutation, i.e. a variant where one DNA letter is changed into another, and now codes for STOP instead of an amino acid. This leads to premature translation stops and non-functional dystrophin.
New drug approved to treat Duchenne muscular dystrophy https://www.ctvnews.ca/london/article/i-think-jesse-would-be-pretty-proud-major-milestone-in-the-fight-against-duchenne-muscular-dystrophy/
Health Canada Grants Approval for AGAMREE® as First Cure for Duchenne Muscular Dystrophy #Canada #Mississauga #Duchenne #AGAMREE #Kye_Pharmaceuticals
Signal or noise? > What is the life expectancy in Duchenne muscular dystrophy? - MedicalNewsToday >> Comment below! #strategy #competitiveintelligence #marketing #pharmaceutical #competitivemarketing #healthcare #biotech #pharma
Signal or noise? > Next-Gen Duchenne Muscular Dystrophy Treatment Update: Solid Bio's Gene Therapy Trial Results Coming - Stock Titan >> Comment below! #strategy #competitiveintelligence #marketing #healthcare #pharma #competitivemarketing #biotech #pharmaceutical
Signal or noise? > Maryville 9-year-old's journey with Duchenne Muscular Dystrophy sparks hope amid challenges - WBIR >> Comment below! #strategy #competitiveintelligence #marketing #biotech #healthcare #pharmaceutical #pharma #competitivemarketing
Tevard Biosciences Presents Data Demonstrating Production of Full-Length Protein with tRNA-Based Therapy for Duchenne Muscular Dystrophy #dmd #duchenne
This observational study evaluated the prevalence and subjective burden of endocrinological complications, including osteoporosis, short stature, and delayed puberty, in 35 boys with Duchenne muscular dystrophy.
Duchenne muscular dystrophy patients face debilitating endocrine issues, but a proactive approach can empower them to manage their health and live fuller lives.
Tevard Biosciences Presents Data Showing Compelling Full-Length Protein Rescue with tRNA-based Treatment for Duchenne Muscular Dystrophy and Dilated Cardiomyopathy at the 2025 FEBS Special Meeting https://www.newsbeep.com/ca/177746/ Treating you—and your story—with courtesy and care. Our …
Tevard Biosciences Presents Data Showing Compelling Full-Length Protein Rescue with tRNA-based Treatment for Duchenne Muscular Dystrophy and Dilated Cardiomyopathy at the 2025 FEBS Special Meeting https://www.newsbeep.com/ie/50606/ Treating you—and your story—with courtesy and care. Our …
Tevard Biosciences reveals breakthrough tRNA therapy restoring 70% protein levels in Duchenne muscular dystrophy and cardiomyopathy models. Promising preclinical results show potential for genetic disease treatment. #Biotech #Genetics
#DYN Dyne Therapeutics Receives Orphan Drug Designation in Japan for DYNE-251 in Duchenne Muscular Dystrophy https://www.stocktitan.net/news/DYN/dyne-therapeutics-receives-orphan-drug-designation-in-japan-for-dyne-8qa3i3on9p47.html
Cures of #Duchenne (Detailed List of All Clinical Trials for #DMD) List of all researches such as #gene therapy, exon skipping, reducing inflammation and improving #muscle growth & protection cures for duchenne #muscular dystrophy. dmdwarrior.com/dmd-treatmen...
Functional and structural pathologies in skeletal muscle of a rat model of Duchenne muscular dystrophy www.biorxiv.org/content/10.1...
Congrats to Kelley Kidwell of University of Michigan on, “Evaluating longitudinal treatment effects for Duchenne muscular dystrophy using dynamically enriched Bayesian small sample, sequential, multiple assignment randomized trial.” We’re proud to facilitate your data access.
New Insights on Givinostat's Efficacy for Duchenne Muscular Dystrophy Unveiled at NMSG Meeting 2025 #United_States #Massachusetts #ITF_Therapeutics #DMD #givinostat
For exon skipping several ASOs are approved in the USA for Duchenne muscular dystrophy, but preclinically it has also been used for e.g. limb girdle muscular dystrophy. Authors outline that chemical modifications of ASOs are needed for stability and drug like properties.
This multicenter study evaluated the efficacy of corticosteroids in 53 boys with Duchenne muscular dystrophy (DMD) over 1.2 years.
SDBN Trending: Capricor Therapeutics Provides Regulatory Update on Deramiocel Program for Duchenne Muscular Dystrophy Following Type A Meeting https://zpr.io/2sqbjUJU974H
#CAPR Capricor Therapeutics Provides Regulatory Update on Deramiocel Program for Duchenne Muscular Dystrophy Following Type A Meeting https://www.stocktitan.net/news/CAPR/capricor-therapeutics-provides-regulatory-update-on-deramiocel-9kdz0pllx8oo.html
A unified model for Duchenne muscular dystrophy gene involvement in cancer: context-dependent tumour suppression and oncogenicity
‘We seize every moment’: Family shares son’s journey with Duchenne muscular dystrophy www.ctvnews.ca/calgary/arti...
A #Canmore family is making every moment count with their six-year-old son, Oliver (Ollie) Masnada, who has been diagnosed with Duchenne muscular dystrophy—a progressive genetic disorder with no cure. More here
Mutations that affect costemeric proteins lead to muscular dystrophies, underlining the importance of the costamere system. An example of such a disease is Duchenne muscular dystrophy, where dystrophin is lacking. Without dystrophin muscle fibers are damaged during contraction.
Duchenne muscular dystrophy is driven by defective membrane repair and annexin-A2 dysregulation in skeletal muscle https://www.biorxiv.org/content/10.1101/2025.09.23.677988v1
Duchenne muscular dystrophy is driven by defective membrane repair and annexin-A2 dysregulation in skeletal muscle https://www.biorxiv.org/content/10.1101/2025.09.23.677988v1
Lymphatic dysfunction is linked to disease pathogenesis in Duchenne muscular dystrophy animal models www.pnas.org/doi/10.1073/...
JMIR Formative Res: Exploring the Role of Telemedicine in Duchenne Muscular Dystrophy: Benefits and Challenges #Telemedicine #DuchenneMuscularDystrophy #DMD #GeneticResearch #HealthcareInnovation
Duchenne Muscular Dystrophy is the most common fatal genetic disorder diagnosed in childhood.
FDA Approves Orphan Drug Status for NS-051/NCNP-04 to Combat Duchenne Muscular Dystrophy #United_States #NS_Pharma #Paramus #Duchenne_Muscular_Dystrophy #NS-051
New #PNAS paper: Lymphatic dysfunction is linked to disease pathogenesis in Duchenne muscular dystrophy animal models. #Myoblue tinyurl.com/4anzhr3u
Endocrinological complications of Duchenne muscular dystrophy and their subjective burden: observational study evaluating growth, puberty, and bone health. M Rohlenova et al. J Endocrinol Invest 2025 Sep 16 shorturl.at/fxrRy
The rise of rat models for Duchenne muscular dystrophy and therapeutic evaluations skeletalmusclejournal.biomedcentral.com/articles/10....
Functional and structural pathologies in skeletal muscle of a rat model of Duchenne muscular dystrophy https://www.biorxiv.org/content/10.1101/2025.09.11.675592v1
Functional and structural pathologies in skeletal muscle of a rat model of Duchenne muscular dystrophy https://www.biorxiv.org/content/10.1101/2025.09.11.675592v1
Meet 2025 Next Generation Research Grant recipient Sophie Rengarajan, MD, PhD, of UCLA Medical Center. Dr. Rengarajan is studying gene-expression changes in Duchenne #MuscularDystrophy (#DMD). Funded with the Neuromuscular Study Group and @aanmember.bsky.social.
✅ Real success stories: from children with Duchenne Muscular Dystrophy to patients where traditional treatments failed. ✅ Tissue repair, immune balance & new cell activation – a new chance at life.
This weekend, 9-year-old Jerick MayRobb stepped up to the mound — not just for the game — but for every kid battling Duchenne Muscular Dystrophy. #GoodNews
Belief BioMed Announced Successful Completion of First Dose of BBM-D101 Gene Therapy #dmd #duchenne #BBMD101 #BeliefBioMed #clinicaltrials
Anthony Higgins has Duchenne muscular dystrophy, a progressive genetic disorder causing muscle weakness, that leaves him unable to walk
Keros Therapeutics Presents Additional Clinical Data from its KER-065 Program at the American Society of Bone and Mineral Research 2025 Annual Meeting #dmd #duchenne #ker065
The National Institute for Health and Care Excellence has published its first assessment of an externally produced clinical guideline, which focuses on the cardiac care of children with Duchenne muscular dystrophy #ukpharmacy #musculardystrophy
Did you know that I carry Duchenne Muscular Dystrophy and have two sons with this terminal genetic illness? 9/7 is World Duchenne Awareness Day! #CureDuchenne #WorldDuchenneAwarenessDay #duchenneawareness #duchennemusculardystrophy #duchenne
Member publication alert: Regional 4D Cardiac Magnetic Resonance Strain Predicts Cardiomyopathy Progression in Duchenne Muscular Dystrophy www.sciencedirect.com/science/arti...
Did you know that I carry Duchenne Muscular Dystrophy and have two sons with this terminal genetic illness? Today is World Duchenne Awareness Day! Do you know that this is one of the leading causes of pediatric death? #CureDuchenne #WorldDuchenneAwarenessDay #duchennemusculardystrophy
Exclusive: Alison Joseph's sons Noah and Hunter both have Duchenne muscular dystrophy. She tells Rhian Lubin the heartbreaking reality of watching one thrive while the other suffers
Two brothers have the same genetic disorder. Their insurance only covered life-altering treatment for one of them They both have Duchenne muscular dystrophy. She tells Rhian Lubin the heartbreaking reality of watching one thrive while the other suffers www.the-independent.com/news/world/a...
Also, today is World Duchenne Muscular Dystrophy (DMD) Awareness Day, as recognized by the United Nations. Learn more here: www.un.org/en/observanc....
Today is Duchenne Muscular Dystrophy Awareness Day! Please visit www.worldduchenneday.org/ to learn more. #duchennemusculardystrophy #dmd #awareness
(1/3) #DidYouKnow? Today is #WorldDuchenneAwarenessDay and September is Duchenne Awareness Month in Canada.
On #DuchenneAwarenessDay, we celebrate the power of patient advocacy. When Alex Johnson OBE and Emily Reuben OBE founded Duchenne UK, their shared mission was clear: to end Duchenne muscular dystrophy. In just over a decade, their work has transformed care across the UK.
GNR-097: Duchenne Gene Therapy Phase 1/2 Study Started by Generium Generium is a Russian innovative biotechnology company has received approval to conduct a clinical trial of GNR-097 gene therapy drug for the treatment of progressive Duchenne muscular dystrophy (DMD).
How Does My Child Participate in Clinical Trials for Duchenne? Learn how your child can join Duchenne muscular dystrophy (DMD) clinical trials and discover trusted resources to find active studies near you. Learn More
Scientists develop way to make DMD treatments work better https://www.newsbeep.com/ca/120803/ Researchers have developed a way to enhance the efficacy of exon-skipping therapies for Duchenne muscular dystrophy (DMD), and…
This week on 7th September is World Duchenne Awareness Day. It's held on 7/9 in recognition of the 79 exons on the Dystrophin gene. A small genetic fault in just one of these exons is all it takes to cause Duchenne Muscular Dystrophy, a life-limiting muscle-wasting disease.
Red Deer to light up for World Duchenne Awareness Day https://www.newsbeep.com/ca/118029/ An explainer on the genetics behind Duchenne is at defeatduchenne.com. “Duchenne muscular dystrophy impacts far more than the…
Excited to share that our new review in Frontiers in Cell and Developmental Biology is now out! "Stem/progenitor cell-based therapy for Duchenne muscular dystrophy" Check it out!
Get ready for a heartwarming day in Tombstone as the community unites for "Trucking for Tommy," a fundraiser packed with fun activities to support a brave five-year-old battling Duchenne muscular dystrophy! Click to read more! #CochiseCounty #AZ #CitizenPortal #CommunitySupport #TombstoneEvents
Tags: cellular therapy, research, neuro muscular disorders treatment, duchenne muscular dystrophy cure research, mnd als new treatment india, neuro orthopedic expert india, best doctor cellular therapy india, top neuro muscular disorder specialist #CellularTherapy #GutMuscleBrainAxis #drbsrajput
RT @oligogirl: Today is D-Day: #WDAD2021. This will be the last 'behind the paper' tweet featuring the Duchenne Muscular Dystrophy publicat…
Today is D-Day: #WDAD2021. This will be the last 'behind the paper' tweet featuring the Duchenne Muscular Dystrophy publication that appeared earlier this year in Nature Review Disease Primers @MethodsPrimers https://t.co/y90WBnayXU
RT @AmbrizMau: Algoritmo sobre la decisión diagnóstica para confirmar el diagnóstico genético de distrofinopatías: Nat Rev Dis Primers 202…
RT @AmbrizMau: Algoritmo sobre la decisión diagnóstica para confirmar el diagnóstico genético de distrofinopatías: Nat Rev Dis Primers 202…
RT @AmbrizMau: Algoritmo sobre la decisión diagnóstica para confirmar el diagnóstico genético de distrofinopatías: Nat Rev Dis Primers 202…
RT @AmbrizMau: Algoritmo sobre la decisión diagnóstica para confirmar el diagnóstico genético de distrofinopatías: Nat Rev Dis Primers 202…
RT @AmbrizMau: Algoritmo sobre la decisión diagnóstica para confirmar el diagnóstico genético de distrofinopatías: Nat Rev Dis Primers 202…
RT @AmbrizMau: Algoritmo sobre la decisión diagnóstica para confirmar el diagnóstico genético de distrofinopatías: Nat Rev Dis Primers 202…
RT @AmbrizMau: Algoritmo sobre la decisión diagnóstica para confirmar el diagnóstico genético de distrofinopatías: Nat Rev Dis Primers 202…
RT @AmbrizMau: Algoritmo sobre la decisión diagnóstica para confirmar el diagnóstico genético de distrofinopatías: Nat Rev Dis Primers 202…
RT @AmbrizMau: Algoritmo sobre la decisión diagnóstica para confirmar el diagnóstico genético de distrofinopatías: Nat Rev Dis Primers 202…
Algoritmo sobre la decisión diagnóstica para confirmar el diagnóstico genético de distrofinopatías: Nat Rev Dis Primers 2021; DOI: https://t.co/eC6cEnO3Un https://t.co/p2FiGISuWD
RT @MedClubPage:
RT @AmbrizMau: Histología de músculo sano comparado con distrofia muscular de Duchenne: Nat Rev Dis Primers 2021; DOI: https://t.co/eC6cEn…
RT @AmbrizMau: Histología de músculo sano comparado con distrofia muscular de Duchenne: Nat Rev Dis Primers 2021; DOI: https://t.co/eC6cEn…
RT @AmbrizMau: Histología de músculo sano comparado con distrofia muscular de Duchenne: Nat Rev Dis Primers 2021; DOI: https://t.co/eC6cEn…
RT @AmbrizMau: Histología de músculo sano comparado con distrofia muscular de Duchenne: Nat Rev Dis Primers 2021; DOI: https://t.co/eC6cEn…
RT @AmbrizMau: Histología de músculo sano comparado con distrofia muscular de Duchenne: Nat Rev Dis Primers 2021; DOI: https://t.co/eC6cEn…
RT @AmbrizMau: Histología de músculo sano comparado con distrofia muscular de Duchenne: Nat Rev Dis Primers 2021; DOI: https://t.co/eC6cEn…
RT @AmbrizMau: Histología de músculo sano comparado con distrofia muscular de Duchenne: Nat Rev Dis Primers 2021; DOI: https://t.co/eC6cEn…
RT @AmbrizMau: Histología de músculo sano comparado con distrofia muscular de Duchenne: Nat Rev Dis Primers 2021; DOI: https://t.co/eC6cEn…
RT @AmbrizMau: Histología de músculo sano comparado con distrofia muscular de Duchenne: Nat Rev Dis Primers 2021; DOI: https://t.co/eC6cEn…
RT @AmbrizMau: Histología de músculo sano comparado con distrofia muscular de Duchenne: Nat Rev Dis Primers 2021; DOI: https://t.co/eC6cEn…
RT @AmbrizMau: Histología de músculo sano comparado con distrofia muscular de Duchenne: Nat Rev Dis Primers 2021; DOI: https://t.co/eC6cEn…
RT @AmbrizMau: Histología de músculo sano comparado con distrofia muscular de Duchenne: Nat Rev Dis Primers 2021; DOI: https://t.co/eC6cEn…
RT @AmbrizMau: Histología de músculo sano comparado con distrofia muscular de Duchenne: Nat Rev Dis Primers 2021; DOI: https://t.co/eC6cEn…
RT @AmbrizMau: Histología de músculo sano comparado con distrofia muscular de Duchenne: Nat Rev Dis Primers 2021; DOI: https://t.co/eC6cEn…
RT @AmbrizMau: Histología de músculo sano comparado con distrofia muscular de Duchenne: Nat Rev Dis Primers 2021; DOI: https://t.co/eC6cEn…
RT @AmbrizMau: Histología de músculo sano comparado con distrofia muscular de Duchenne: Nat Rev Dis Primers 2021; DOI: https://t.co/eC6cEn…
RT @AmbrizMau: Histología de músculo sano comparado con distrofia muscular de Duchenne: Nat Rev Dis Primers 2021; DOI: https://t.co/eC6cEn…
RT @AmbrizMau: Histología de músculo sano comparado con distrofia muscular de Duchenne: Nat Rev Dis Primers 2021; DOI: https://t.co/eC6cEn…
RT @AmbrizMau: Histología de músculo sano comparado con distrofia muscular de Duchenne: Nat Rev Dis Primers 2021; DOI: https://t.co/eC6cEn…
Histología de músculo sano comparado con distrofia muscular de Duchenne: Nat Rev Dis Primers 2021; DOI: https://t.co/eC6cEnO3Un https://t.co/bcA6Uc6VLk
RT @MedClubPage:
RT @MedClubPage:
RT @MedClubPage:
RT @MedClubPage:
RT @MedClubPage:
RT @MedClubPage:
RT @MedClubPage:
RT @MedClubPage:
MA
S
M
SB
MK
OS
ST
DC
TA
GG
AB
JG
DC
PM
HS
CG
MH
B
H
TR
CC
CE
WW
MA
JT
DY
LC
A
CB
JP
WL
Y朱
DH
DJ
MG
SB
EE
MU
MN
C
DM
RD
CI
HF
SM
C
E
MM
GE
JH
J
MM
EM
S
TY
EP
O
O
EW
LW
D
LR
M
IM
S
R
S
NS
DC
CI
NP
AR
GN
VG
DA
E
SV
RL
B
V
JS
CR
MM
JL
DC
DF
SC
L
O
PO
GT
R
LA
KG
TA
A
RF
MV
GN
DG
JE
CA
K
DL
MS
ET
DM
PC